Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies

doi:10.3748/wjg.v21.i38.10776

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8674)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

599

WORD

245

HTML

3909

Figures (1-1)

137

Sum=4890

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

525

Download

1023

Sum=1548

Publishing Process of This Article

Item

Count

Browse

984

Download

1252

Sum=2236

Oct 14, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 14, 2015; 21(38): 10776-10782
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10776

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic representation of hepatitis C virus and host interplay during hepatitis C virus infection. Viral infection has a direct effect on lipid metabolism through two main mechanisms: first, by deregulating gene expression (FASN, DGAT, MTTP, SREBP). This effect can be modulated by certain SNPs in PNPLA3, among others. Secondly, VLDL synthesis is affected, since HCV replication takes place on lipid droplets. SNPs: Single nucleotide polymorphisms; VLDL: Very low-density lipoprotein; HCV: Hepatitis C virus; DGAT: Diacylglycerol acyltransferase; LD: Lipid droplet; PNPLA3: patatin-like phospholipase domain containing 3.

Citation: Del Campo JA, Romero-Gómez M. Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies. World J Gastroenterol 2015; 21(38): 10776-10782
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10776.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10776